Free Trial
NASDAQ:ACB

Aurora Cannabis (ACB) Stock Price, News & Analysis

Aurora Cannabis logo
$4.34 +0.04 (+0.93%)
(As of 11/22/2024 ET)

About Aurora Cannabis Stock (NASDAQ:ACB)

Key Stats

Today's Range
$4.29
$4.45
50-Day Range
$4.18
$6.11
52-Week Range
$2.84
$9.35
Volume
896,185 shs
Average Volume
3.00 million shs
Market Capitalization
$238.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Buy

Company Overview

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Aurora Cannabis Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
10th Percentile Overall Score

ACB MarketRank™: 

Aurora Cannabis scored higher than 10% of companies evaluated by MarketBeat, and ranked 908th out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Aurora Cannabis are expected to decrease in the coming year, from ($0.02) to ($0.03) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aurora Cannabis is -5.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aurora Cannabis is -5.71, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Aurora Cannabis has a P/B Ratio of 0.56. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Aurora Cannabis' valuation and earnings.
  • Percentage of Shares Shorted

    5.16% of the float of Aurora Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    Aurora Cannabis has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aurora Cannabis has recently increased by 6.84%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aurora Cannabis does not currently pay a dividend.

  • Dividend Growth

    Aurora Cannabis does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    5.16% of the float of Aurora Cannabis has been sold short.
  • Short Interest Ratio / Days to Cover

    Aurora Cannabis has a short interest ratio ("days to cover") of 2.7, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aurora Cannabis has recently increased by 6.84%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Aurora Cannabis has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Aurora Cannabis this week, compared to 3 articles on an average week.
  • Search Interest

    Only 21 people have searched for ACB on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.
  • MarketBeat Follows

    7 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is an increase of 133% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aurora Cannabis insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.01% of the stock of Aurora Cannabis is held by insiders.

  • Percentage Held by Institutions

    47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aurora Cannabis' insider trading history.
Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

ACB Stock News Headlines

Short Interest in Aurora Cannabis Inc. (NASDAQ:ACB) Expands By 6.8%
Buffett Dumps $982 Million in BofA Stock—What Does He Know?
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.
Atb Cap Markets Weighs in on Aurora Cannabis Q3 Earnings
Roth MKM Sticks to Their Hold Rating for Aurora Cannabis (ACB)
See More Headlines

ACB Stock Analysis - Frequently Asked Questions

Aurora Cannabis' stock was trading at $4.7620 on January 1st, 2024. Since then, ACB shares have decreased by 8.9% and is now trading at $4.34.
View the best growth stocks for 2024 here
.

Aurora Cannabis Inc. (NASDAQ:ACB) announced its quarterly earnings results on Wednesday, May, 12th. The company reported ($8.20) EPS for the quarter, missing the consensus estimate of ($1.70) by $6.50. The firm had revenue of $43.56 million for the quarter, compared to the consensus estimate of $55.17 million. Aurora Cannabis had a negative net margin of 17.47% and a negative trailing twelve-month return on equity of 2.19%.

Shares of Aurora Cannabis reverse split on Tuesday, February 20th 2024. The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

The following companies are subsidiaries of Aurora Cannabis: Reliva LLC, Whistler Medical Marijuana Corporation, ICC Labs Inc., Anandia Labs Inc, MedReleaf Corp., CanniMed Therapeutics Inc., Larssen Ltd, and others.

Aurora Cannabis' top institutional investors include Parallax Volatility Advisers L.P., Centiva Capital LP (0.08%), Wolverine Trading LLC and Belvedere Trading LLC.

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aurora Cannabis investors own include Canopy Growth (CGC), Cronos Group (CRON), NVIDIA (NVDA), Meta Platforms (META), Humana (HUM), Marinus Pharmaceuticals (MRNS) and American Water Works (AWK).

Company Calendar

Last Earnings
5/12/2021
Today
11/22/2024
Next Earnings (Estimated)
2/13/2025
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ACB
Fax
N/A
Employees
1,073
Year Founded
2006

Profitability

Net Income
$-48,620,000.00
Pretax Margin
-22.05%

Debt

Sales & Book Value

Annual Sales
$296.99 million
Cash Flow
$0.23 per share
Book Value
$7.79 per share

Miscellaneous

Free Float
54,838,000
Market Cap
$238.02 million
Optionable
Optionable
Beta
1.87

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (NASDAQ:ACB) was last updated on 11/22/2024 by MarketBeat.com Staff
From Our Partners